USD 1001.59 Million
Global MicroRNA Market Size, Share, Growth Analysis, By Research Tool(Service and product), By End-use(Biotechnology and pharmaceutical companies, academic and government research institutes) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2216 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
61 |
Figures:
75
Global MicroRNA Market Insights
MicroRNA Market size was valued at USD 1001.59 Million in 2021 and is poised to grow from USD 1173.86 Million in 2022 to USD 4178.66 Million by 2030, at a CAGR of 17.2% during the forecast period (2023-2030).
The global microRNA market has witnessed significant growth in recent years, driven by advancements in molecular biology, genomics, and bioinformatics. MicroRNAs (miRNAs) are small non-coding RNA molecules that play a crucial role in gene expression regulation, making them valuable biomarkers for various diseases and potential targets for therapeutic interventions. The increasing understanding of miRNA's role in disease pathways and their potential as diagnostic and therapeutic tools has fueled the market growth. The market growth is also attributed to the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. MicroRNAs have demonstrated promising potential in disease diagnosis, prognosis, and therapy, leading to increased research activities and investments in the field. Additionally, the development of advanced technologies for miRNA profiling and detection, such as next-generation sequencing and microarray platforms, has facilitated the analysis and identification of miRNA biomarkers, further driving market growth. However, the global microRNA market faces several challenges that need to be addressed for sustained growth. One of the key challenges is the complex regulatory landscape surrounding miRNA-based therapeutics and diagnostics. The approval process for miRNA-based products involves stringent regulatory requirements and clinical trials, which can be time-consuming and costly. Ensuring the safety, efficacy, and specificity of miRNA-based interventions poses a significant challenge for researchers and industry players. Another challenge is the limited understanding of miRNA functions and their complex interactions within biological systems. MiRNA research requires comprehensive studies to elucidate their specific roles in disease mechanisms and to identify reliable and accurate biomarkers. Furthermore, the development of effective delivery systems for miRNA-based therapeutics remains a challenge due to the need for targeted delivery and stability in vivo. Despite these challenges, the global microRNA market presents significant opportunities for further growth and innovation. Advancements in technologies, increased research efforts, and collaborations between academic institutions and industry players are expected to drive the development of novel miRNA-based diagnostics and therapeutics.
US MicroRNA Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Product
Fastest Growth
Product
Growth Rate
17.2% CAGR
Global MicroRNA Market ($ Bn)
Country Share for North America Region (%)
Global MicroRNA Market By Research tool ($ Bn)
Global MicroRNA Market By Research tool (%)
To get more reports on the above market click here to Buy The Report
Global MicroRNA Market Segmental Analysis
Global MicroRNA Market is segmented on the basis of research tool, end-user, and region. By research tool, the market is segmented into services and products. By end use, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutes, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
MicroRNA Market Analysis By Research Tool
The global microRNA market can be segmented by research tools into services and products. Among these segments, products hold a dominant position, while services are experiencing the fastest growth. The dominance of the products segment can be attributed to the availability of a wide range of miRNA-related products, including miRNA isolation kits, miRNA quantification assays, miRNA expression profiling arrays, and miRNA functional analysis tools. These products are widely used by researchers in academia and the pharmaceutical industry for miRNA research and analysis. The market for miRNA products is driven by the increasing demand for reliable and efficient tools that enable the identification, quantification, and characterization of miRNAs in various biological samples.
On the other hand, the services segment is witnessing rapid growth in the global microRNA market. These services encompass miRNA profiling, miRNA expression analysis, miRNA target prediction, and custom miRNA synthesis, among others. Service providers offer specialized expertise and advanced technologies to assist researchers in their miRNA-related studies. The growing complexity of miRNA research and the need for specialized analysis techniques have led to an increased reliance on service providers who can offer tailored solutions and expert guidance. Additionally, outsourcing miRNA-related services can save time and resources for researchers, further driving the growth of this segment.
MicroRNA Market Analysis By End Use
The global microRNA market can be segmented by end use into biotechnology and pharmaceutical companies, academic and government research institutes, and others. Among these segments, biotechnology and pharmaceutical companies hold a dominant position, while academic and government research institutes are experiencing the fastest growth. Biotechnology and pharmaceutical companies dominate the microRNA market due to their significant investments in research and development, as well as their focus on developing miRNA-based therapeutics and diagnostics. These companies have the resources and expertise to conduct extensive research, clinical trials, and commercialization of miRNA-based products. The growing interest in personalized medicine and targeted therapies has further fueled the demand for miRNA-related solutions in the biotech and pharmaceutical sectors. These companies are actively engaged in developing miRNA-based drugs, biomarkers, and diagnostic tools, making them a dominant force in the microRNA market.
On the other hand, academic and government research institutes are witnessing rapid growth in their adoption and utilization of microRNAs. These institutes play a crucial role in advancing miRNA research by conducting fundamental studies, elucidating miRNA functions, and exploring their potential applications in various diseases. Academic and government research institutes often collaborate with industry players and contribute to the discovery of new miRNA biomarkers, identification of therapeutic targets, and development of innovative miRNA-based interventions. The growth in funding for research programs, along with the emphasis on translational research, has contributed to the increased adoption of microRNAs in academic and government research institutes.
Global MicroRNA Market By Research tool, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global MicroRNA Market Regional Insights
North America dominates the microRNA market due to the presence of a well-established healthcare infrastructure, significant investments in research and development, and a strong biotechnology and pharmaceutical industry. The region is home to several key market players and academic research institutes actively engaged in miRNA research. Additionally, favorable government initiatives, collaborations between academia and industry, and the availability of advanced technologies contribute to the dominance of North America in the microRNA market.
On the other hand, the Asia Pacific region is witnessing the fastest growth in the microRNA market. The growth is driven by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, and growing awareness about personalized medicine. Countries like China, India, and Japan are leading the growth in the region due to their large population base, expanding biotechnology and pharmaceutical sectors, and rising investments in research and development. Furthermore, collaborations between international players and local research institutions are fostering the advancement of miRNA research in the Asia Pacific region.
Global MicroRNA Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global MicroRNA Market Dynamics
MicroRNA Market Drivers
Advancements in Genomics and Molecular Biology Technologies
- Technological advancements in genomics and molecular biology, such as next-generation sequencing and microarray platforms, have enabled high-throughput analysis of microRNAs. These technologies provide researchers with valuable tools to identify and characterize microRNAs, leading to increased research activities and driving market growth.
Rising Prevalence of Chronic Diseases
- The global burden of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, is increasing. MicroRNAs have shown promising potential as biomarkers for the early detection and diagnosis of these diseases. The need for accurate and non-invasive diagnostic tools has contributed to the demand for microRNA research and development.
MicroRNA Market Restraints
Limited Understanding of microRNA Functions
- Although microRNAs have been extensively studied, there is still much to discover about their precise functions and mechanisms of action. The limited understanding of microRNA biology poses challenges in identifying reliable and specific biomarkers and developing effective therapeutic interventions.
Technical and Analytical Challenges
- MicroRNA research involves technical and analytical challenges, such as accurate quantification, sample variability, and standardization of analysis methods. These challenges can impact the reproducibility and reliability of microRNA research results, hindering the market growth.
Request Free Customization of this report to help us to meet your business objectives.
Global MicroRNA Market Competitive Landscape
The global microRNA market is characterized by a highly competitive landscape, with numerous players striving to establish their presence and gain a competitive edge. The market is driven by intense research and development activities aimed at discovering novel microRNA biomarkers, therapeutic targets, and diagnostic tools. These advancements are fueling the development of innovative microRNA-based products and solutions, further intensifying the competition among market participants. Key players in the global microRNA market include biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations. These entities contribute to the market by conducting extensive research, clinical trials, and commercialization of microRNA-based products. Furthermore, collaborations and partnerships between industry players and research institutions are common, allowing for knowledge sharing and synergistic advancements. Market participants strive to differentiate themselves by offering a wide range of microRNA-related products and services, including miRNA isolation kits, miRNA quantification assays, miRNA expression profiling arrays, miRNA functional analysis tools, and miRNA sequencing services. Additionally, companies focus on developing proprietary technologies and platforms that enhance the efficiency, accuracy, and sensitivity of microRNA analysis. To stay competitive, market players engage in strategic initiatives such as mergers and acquisitions, partnerships, and collaborations. These activities help them expand their product portfolios, strengthen their market presence, and access new geographical markets. Furthermore, companies invest in research and development to drive innovation and maintain a pipeline of cutting-edge microRNA-based products. The competitive landscape is also influenced by intellectual property rights and patent protection. Securing patents for novel microRNA-related discoveries and technologies is crucial for market players to safeguard their innovations and maintain a competitive advantage.
MicroRNA Market Top Player’s Company Profile
- Qiagen N.V. - Netherlands
- Thermo Fisher Scientific Inc. - US
- Agilent Technologies, Inc. - US
- Illumina, Inc. - US
- Merck KGaA - Germany
- F. Hoffmann-La Roche Ltd. - Switzerland
- Bio-Rad Laboratories, Inc. - US
- PerkinElmer, Inc. - US
- System Biosciences LLC - US
- New England Biolabs, Inc. - US
- NanoString Technologies, Inc. - US
- Exiqon A/S - Denmark
- Takara Bio Inc. - Japan
- GenScript Biotech Corporation - US
- Eurofins Scientific SE - Luxembourg
- Novartis AG - Switzerland
- Bio-Techne Corporation - US
- Agios Pharmaceuticals, Inc. - US
- Abcam plc - United Kingdom
- Promega Corporation - US
MicroRNA Market Recent Developments
- In February 2022, A team of researchers from the University of Illinois Urbana has successfully developed an innovative point-of-care test for cancer detection, focusing on microRNAs (miRNAs). The test utilizes nanoparticles to effectively capture tumor-specific miRNAs present in human serum. This breakthrough in technology offers a promising approach for quick and reliable cancer screening at the point of care.
- In August 2022, MiRXES, a biotechnology company based in Singapore, has recently introduced several advancements to enhance its research and production capabilities in the field of miRNA-based disease detection tests. These developments include the establishment of an Industry 4.0 (i4.0) manufacturing facility, the addition of two state-of-the-art laboratories, and the initiation of a collaborative multi-cancer screening research project. These strategic initiatives demonstrate MiRXES' commitment to advancing its capabilities and positioning itself at the forefront of miRNA research and diagnostics.
Global MicroRNA Key Market Trends
- Growing Collaboration between Industry and Academia: Collaborations between biotechnology and pharmaceutical companies, academic research institutions, and government organizations are increasingly common in microRNA research. These collaborations leverage the expertise, resources, and knowledge of multiple stakeholders to accelerate the development and commercialization of microRNA-based products and solutions.
- Rising Adoption of MicroRNAs in Disease Biomarker Research: MicroRNAs hold great potential as biomarkers for various diseases due to their stable presence in different biological fluids. Research efforts are focused on identifying specific microRNA signatures associated with diseases, allowing for early detection, accurate diagnosis, and prognosis prediction. The rising adoption of microRNAs as disease biomarkers is driving market growth.
Global MicroRNA Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, the global microRNA market is witnessing significant growth and holds immense potential for advancements in healthcare and personalized medicine. MicroRNAs, as key regulators of gene expression, have emerged as valuable tools for disease diagnosis, prognosis, and therapeutic interventions. The market is driven by factors such as the increasing demand for personalized medicine, advancements in genomics and molecular biology technologies, and the rising prevalence of chronic diseases. The integration of microRNAs in precision medicine approaches and the emergence of therapeutic applications further propel market growth. Technological advancements in microRNA analysis, collaborations between industry and academia, and the growing focus on liquid biopsy and disease biomarker research are key trends shaping the market. However, challenges such as the complex regulatory landscape, limited understanding of microRNA functions, and technical and analytical hurdles exist. Despite these challenges, the global microRNA market is poised for continued expansion with the potential to revolutionize disease management and contribute to improved patient outcomes. As research efforts and investments in microRNA-related studies continue to grow, the market is expected to witness remarkable advancements and play a significant role in shaping the future of healthcare.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1001.59 Million |
| Market size value in 2031 | USD 4178.66 Million |
| Growth Rate | 17.2% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global MicroRNA Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global MicroRNA Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global MicroRNA Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global MicroRNA Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global MicroRNA Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global MicroRNA Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global MicroRNA Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
